UNANIMOUS SHAREHOLDERS AGREEMENTUnanimous Shareholders Agreement • September 29th, 2014 • Advanced Accelerator Applications S.A. • Pharmaceutical preparations • Ontario
NOW THEREFORE THIS AGREEMENT WITNESSES THAT, in consideration of the mutual covenants and agreement herein contained and other good and valuable consideration, the parties hereto agree as follows:
CLINICAL SERVICES AGREEMENTClinical Services Agreement • September 29th, 2014 • Advanced Accelerator Applications S.A. • Pharmaceutical preparations
THIS CLINICAL SERVICES AGREEMENT (together with all corresponding Exhibits, "AGREEMENT") is entered into as the 1st of November 2011 by and between Advanced Accelerator Applications, with registered office in Saint-Genis-Pouilly, 20 rue Diesel, France ("SPONSOR"), and Pierrel Research Italy Spa ("CRO"), with registered office in Via Pietro Mascagni 14, Milan, Italy and operational offices in Italy, in Sesto S. Giovanni (MI), Via Alberto Falck 15 and in Cantù (CO), Via Como 5.
License Agreement between Mallinckrodt Inc. and BioSynthema Inc.License Agreement • September 29th, 2014 • Advanced Accelerator Applications S.A. • Pharmaceutical preparations • Missouri
This License Agreement dated the 10th day of October, 2007 (the “Effective Date”), is entered into by and between Mallinckrodt Inc., a corporation organized and existing under the laws of the State of Delaware and having its principal offices at 675 McDonnell Blvd., Hazelwood, MO 63042 (referred to as “Mallinckrodt”), and BioSynthema Inc., a corporation organized and existing under the laws of Missouri, with an office at 4041 Forest Park Avenue, Saint Louis, MO 63108, and its Affiliates (BioSynthema Inc. and its Affiliates are hereafter referred to as “BI”).
